583 related articles for article (PubMed ID: 15979947)
1. Effects of cholecystokinin (CCK)-8 on hypothalamic oxytocin-secreting neurons in rats lacking CCK-A receptor.
Hashimoto H; Onaka T; Kawasaki M; Chen L; Mera T; Soya A; Saito T; Fujihara H; Sei H; Morita Y; Ueta Y
Auton Neurosci; 2005 Aug; 121(1-2):16-25. PubMed ID: 15979947
[TBL] [Abstract][Full Text] [Related]
2. Centrally administered adrenomedullin 5 activates oxytocin-secreting neurons in the hypothalamus and elevates plasma oxytocin level in rats.
Otsubo H; Hyodo S; Hashimoto H; Kawasaki M; Suzuki H; Saito T; Ohbuchi T; Yokoyama T; Fujihara H; Matsumoto T; Takei Y; Ueta Y
J Endocrinol; 2009 Aug; 202(2):237-47. PubMed ID: 19420012
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin-8 increases Fos-like immunoreactivity in the brainstem and myenteric neurons of rats through CCK1 receptors.
Gulley S; Sharma SK; Moran TH; Sayegh AI
Peptides; 2005 Sep; 26(9):1617-22. PubMed ID: 16112401
[TBL] [Abstract][Full Text] [Related]
4. Centrally administered neuropeptide W-30 activates magnocellular neurosecretory cells in the supraoptic and paraventricular nuclei with neurosecretion in rats.
Kawasaki M; Onaka T; Nakazato M; Saito J; Mera T; Hashimoto H; Fujihara H; Okimoto N; Ohnishi H; Nakamura T; Ueta Y
J Endocrinol; 2006 Aug; 190(2):213-23. PubMed ID: 16899556
[TBL] [Abstract][Full Text] [Related]
5. The short chain sugar acid, 2-buten-4-olide, activates oxytocin-secreting neurons but not arginine vasopressin-secreting neurons in the hypothalamus of rats.
Kawasaki M; Yamaga C; Onaka T; Saito J; Mera T; Hashimoto H; Fujihara H; Okimoto N; Ohnishi H; Nakamura T; Ueta Y
Brain Res; 2006 May; 1086(1):133-41. PubMed ID: 16616049
[TBL] [Abstract][Full Text] [Related]
6. Reduced CCK-induced Fos expression in the hindbrain, nodose ganglia, and enteric neurons of rats lacking CCK-1 receptors.
Covasa M; Ritter RC
Brain Res; 2005 Jul; 1051(1-2):155-63. PubMed ID: 16005445
[TBL] [Abstract][Full Text] [Related]
7. Strain differences in myenteric neuron number and CCK1 receptor mRNA expression may account for differences in CCK induced c-Fos activation.
Gulley S; Sharma SK; Mansour M; Sullivan CN; Moran TH; Sayegh AI
Brain Res; 2005 Oct; 1058(1-2):109-19. PubMed ID: 16169531
[TBL] [Abstract][Full Text] [Related]
8. Centrally administered adrenomedullin 2 activates hypothalamic oxytocin-secreting neurons, causing elevated plasma oxytocin level in rats.
Hashimoto H; Hyodo S; Kawasaki M; Mera T; Chen L; Soya A; Saito T; Fujihara H; Higuchi T; Takei Y; Ueta Y
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E753-61. PubMed ID: 15956053
[TBL] [Abstract][Full Text] [Related]
9. Through the central V2, not V1 receptors influencing the endogenous opiate peptide system, arginine vasopressin, not oxytocin in the hypothalamic paraventricular nucleus involves in the antinociception in the rat.
Yang J; Chen JM; Song CY; Liu WY; Wang G; Wang CH; Lin BC
Brain Res; 2006 Jan; 1069(1):127-38. PubMed ID: 16409991
[TBL] [Abstract][Full Text] [Related]
10. LPS-induced Fos expression in oxytocin and vasopressin neurons of the rat hypothalamus.
Matsunaga W; Miyata S; Takamata A; Bun H; Nakashima T; Kiyohara T
Brain Res; 2000 Mar; 858(1):9-18. PubMed ID: 10700590
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic intracerebral prolactin on the oxytocinergic and vasopressinergic system of virgin ovariectomized rats.
Donner N; Neumann ID
Neuroendocrinology; 2009; 90(3):315-22. PubMed ID: 19546517
[TBL] [Abstract][Full Text] [Related]
12. Intravenous CDP-choline activates neurons in supraoptic and paraventricular nuclei and induces hormone secretion.
Eyigor O; Coskun C; Cavun S; Savci V
Brain Res Bull; 2012 Feb; 87(2-3):286-94. PubMed ID: 22138197
[TBL] [Abstract][Full Text] [Related]
13. Fos expression variances in mouse hypothalamus upon physical and osmotic stimuli: co-staining with vasopressin, oxytocin, and tyrosine hydroxylase.
Pirnik Z; Kiss A
Brain Res Bull; 2005 May; 65(5):423-31. PubMed ID: 15833597
[TBL] [Abstract][Full Text] [Related]
14. Centrally administered adrenomedullin increases plasma oxytocin level with induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of the rat.
Serino R; Ueta Y; Hara Y; Nomura M; Yamamoto Y; Shibuya I; Hattori Y; Kitamura K; Kangawa K; Russell JA; Yamashita H
Endocrinology; 1999 May; 140(5):2334-42. PubMed ID: 10218987
[TBL] [Abstract][Full Text] [Related]
15. Exaggerated response of arginine vasopressin-enhanced green fluorescent protein fusion gene to salt loading without disturbance of body fluid homeostasis in rats.
Fujio T; Fujihara H; Shibata M; Yamada S; Onaka T; Tanaka K; Morita H; Dayanithi G; Kawata M; Murphy D; Ueta Y
J Neuroendocrinol; 2006 Oct; 18(10):776-85. PubMed ID: 16965296
[TBL] [Abstract][Full Text] [Related]
16. Involvement of cholecystokinin in baseline and post-prandial whole body insulin sensitivity in rats.
Peitl B; Döbrönte R; Drimba L; Sári R; Varga A; Németh J; Pázmány T; Szilvássy Z
Eur J Pharmacol; 2010 Oct; 644(1-3):251-6. PubMed ID: 20624386
[TBL] [Abstract][Full Text] [Related]
17. Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors.
Shilling PD; Feifel D
Synapse; 2002 Feb; 43(2):134-8. PubMed ID: 11754493
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic regeneration after ethionine-induced acute pancreatitis in rats lacking pancreatic CCK-A receptor gene expression.
Sato T; Niikawa J; Usui I; Imamura T; Yoshida H; Tanaka S; Mitamura K
J Gastroenterol; 2003; 38(7):672-80. PubMed ID: 12898360
[TBL] [Abstract][Full Text] [Related]
19. Gastric distension enhances CCK-induced Fos-like immunoreactivity in the dorsal hindbrain by activating 5-HT3 receptors.
Hayes MR; Covasa M
Brain Res; 2006 May; 1088(1):120-30. PubMed ID: 16630589
[TBL] [Abstract][Full Text] [Related]
20. Centrally administered neuromedin U activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat.
Ozaki Y; Onaka T; Nakazato M; Saito J; Kanemoto K; Matsumoto T; Ueta Y
Endocrinology; 2002 Nov; 143(11):4320-9. PubMed ID: 12399428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
